tiprankstipranks
Trending News
More News >
Aarti Drugs Limited (IN:AARTIDRUGS)
:AARTIDRUGS
India Market

Aarti Drugs Limited (AARTIDRUGS) Financial Statements

Compare
3 Followers

Aarti Drugs Limited Financial Overview

Aarti Drugs Limited's market cap is currently ₹43.36B. The company's EPS TTM is ₹6.9; its P/E ratio is 25.89; and it has a dividend yield of 0.21%. Aarti Drugs Limited is scheduled to report earnings on May 6, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 23.87B₹ 25.09B₹ 27.16B₹ 24.89B₹ 21.55B
Gross Profit₹ 8.45B₹ 3.51B₹ 8.28B₹ 5.04B₹ 6.00B
Operating Income₹ 7.33B₹ 2.78B₹ 2.57B₹ 2.88B₹ 3.88B
EBITDA₹ 2.87B₹ 3.20B₹ 3.12B₹ 3.44B₹ 4.45B
Net Income₹ 1.68B₹ 1.71B₹ 1.66B₹ 2.05B₹ 2.80B
Balance Sheet
Cash & Short-Term Investments₹ 226.10M₹ 89.28M₹ 211.70M₹ 216.12M₹ 88.13M
Total Assets₹ 25.75B₹ 24.32B₹ 24.21B₹ 22.08B₹ 17.66B
Total Debt₹ 6.15B₹ 5.64B₹ 6.09B₹ 5.43B₹ 3.51B
Net Debt₹ 6.08B₹ 5.58B₹ 6.00B₹ 5.21B₹ 3.42B
Total Liabilities₹ 12.05B₹ 11.50B₹ 12.29B₹ 11.72B₹ 8.53B
Stockholders' Equity₹ 13.69B₹ 12.82B₹ 11.92B₹ 10.36B₹ 9.13B
Cash Flow
Free Cash Flow₹ 674.20M₹ 1.33B₹ -304.70M₹ -823.39M₹ 667.19M
Operating Cash Flow₹ 2.45B₹ 3.59B₹ 1.34B₹ 696.36M₹ 1.55B
Investing Cash Flow₹ -1.65B₹ -2.24B₹ -1.64B₹ -1.49B₹ -716.79M
Financing Cash Flow₹ -821.20M₹ -1.36B₹ 165.40M₹ 920.25M₹ -811.29M
Currency in INR

Aarti Drugs Limited Earnings and Revenue History

Aarti Drugs Limited Debt to Assets

Aarti Drugs Limited Cash Flow

Aarti Drugs Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis